TNFRSF1A and Alzheimer disease: Overall, these results showed that Tg-TfRMAb-TNFR treatment modulates several AD-relevant signaling pathways related to Aβ processing and degradation, oligodendrocytes, microglia, RNA processing, neuronal loss, and autophagy, with majority of the proteins being relevant to microglial function.